C. Kratzeisen

发表

Characterization of the chimeric retinoic acid receptor RARα/VDR

K. Ozato, P. Abarzúa, S. Pemrick, 1998, Leukemia.

Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.

P. Malherbe, C. Kratzeisen, Pari Malherbe, 2003, Molecular pharmacology.

Mutational Analysis and Molecular Modeling of the Allosteric Binding Site of a Novel, Selective, Noncompetitive Antagonist of the Metabotropic Glutamate 1 Receptor*

J. Kew, G. Adam, P. Malherbe, 2003, The Journal of Biological Chemistry.

Characterization of [3H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors

T. Woltering, G. Adam, P. Malherbe, 2000, Neuropharmacology.

Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABAB receptors

W. Spooren, E. Prinssen, A. Sleight, 2008, British journal of pharmacology.

Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX 1 Antagonist SB-674042 and the Selective OX 2 Antagonist N -Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-

C. Bissantz, P. Malherbe, C. Kratzeisen, 2010 .

Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo.

P. Malherbe, Gavin Kilpatrick, C. Kratzeisen, 2001, The Journal of pharmacology and experimental therapeutics.

Identification of a critical residue in the transmembrane domain 2 of tachykinin neurokinin 3 receptor affecting the dissociation kinetics and antagonism mode of osanetant (SR 142801) and piperidine-based structures.

C. Bissantz, P. Malherbe, C. Kratzeisen, 2009, Journal of medicinal chemistry.

Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum.

J. Kemp, R. Faull, J. Kew, 2002, Brain research. Molecular brain research.

Opposite effects of Zn on the in vitro binding of [3H]LY354740 to recombinant and native metabotropic glutamate 2 and 3 receptors

S. Nakanishi, P. Malherbe, C. Broger, 2005, Journal of neurochemistry.

Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8.

R. Faull, P. Malherbe, K. Lundstrom, 1999, Brain research. Molecular brain research.

A New Pathway for Vitamin A

C. Kratzeisen, J. Grippo, A. Lovey, 1992 .

Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor.

J. Kemp, G. Adam, P. Malherbe, 2001, Molecular pharmacology.

Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX1 Antagonist SB-674042 and the Selective OX2 Antagonist N-Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA)

C. Bissantz, P. Malherbe, C. Kratzeisen, 2010, Molecular Pharmacology.

Me-Talnetant and Osanetant Interact within Overlapping but Not Identical Binding Pockets in the Human Tachykinin Neurokinin 3 Receptor Transmembrane Domains

W. Spooren, C. Bissantz, P. Malherbe, 2008, Molecular Pharmacology.

Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

T Kendall Harden, Richard C Boucher, T. K. Harden, 2003, Molecular pharmacology.

Characterization of the chimeric retinoic acid receptor RARalpha/VDR.

K. Ozato, P. Abarzúa, S. Pemrick, 1998, Leukemia.